XML 35 R25.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity

Schedule of shareholder's equity


										Accumulated
		Common		Common			Additional			Other						Total
		Stock		Stock Par			Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Value			Capital			Income			Deficit			Equity

		(In thousands, except share amounts)
Consolidated balance at December 31, 2023		55,883,377		$	56		$	1,823,168		$	3,308		$	(1,397,361)		$	429,171
Shares issued under stock option and employee stock purchase plans		229,171			—			3,814			—			—			3,814
Shares issued in underwritten offering, net		9,798,000			10			432,288			—			—			432,298
Stock-based compensation		—			—			7,202			—			—			7,202
Unrealized loss on marketable securities		—			—			—			(1,064)			—			(1,064)
Net loss		—			—			—			—			(32,808)			(32,808)
Consolidated balance at March 31, 2024		65,910,548		$	66		$	2,266,472		$	2,244		$	(1,430,169)		$	838,613
Shares issued under stock option and employee stock purchase plans		370,119			—			3,712			—			—			3,712
Stock-based compensation		—			—			7,640			—			—			7,640
Unrealized loss on marketable securities		—			—			—			(464)			—			(464)
Net loss		—			—			—			—			(35,842)			(35,842)
Consolidated balance at June 30, 2024		66,280,667		$	66		$	2,277,824		$	1,780		$	(1,466,011)		$	813,659
Shares issued under stock option and employee stock purchase plans		63,569			—			1,239			—			—			1,239
Stock-based compensation		—			—			9,620			—			—			9,620
Unrealized gain on marketable securities		—			—			—			3,508			—			3,508
Net loss		—			—			—			—			(42,121)			(42,121)
Consolidated balance at September 30, 2024		66,344,236		$	66		$	2,288,683		$	5,288		$	(1,508,132)		$	785,905


										Accumulated
		Common		Common			Additional			Other						Total
		Stock		Stock Par			Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Value			Capital			Income			Deficit			Equity

		(In thousands, except share amounts)
Consolidated balance at December 31, 2022		47,200,695		$	47		$	1,580,829		$	1,260		$	(1,255,932)		$	326,204
Shares issued under stock option and employee stock purchase plans		43,986			—			694			—			—			694
Stock-based compensation		—			—			4,340			—			—			4,340
Unrealized gain on marketable securities		—			—			—			863			—			863
Net loss		—			—			—			—			(29,361)			(29,361)
Consolidated balance at March 31, 2023		47,244,681		$	47		$	1,585,863		$	2,123		$	(1,285,293)		$	302,740
Shares issued under stock option and employee stock purchase plans		9,132			—			133			—			—			133
Stock-based compensation		—			—			5,217			—			—			5,217
Unrealized loss on marketable securities		—			—			—			(51)			—			(51)
Net loss		—			—			—			—			(30,502)			(30,502)
Consolidated balance at June 30, 2023		47,253,813		$	47		$	1,591,213		$	2,072		$	(1,315,795)		$	277,537
Shares issued under stock option and employee stock purchase plans		10,384			—			257			—			—			257
Stock-based compensation		—			—			7,121			—			—			7,121
Unrealized gain on marketable securities		—			—			—			63			—			63
Net loss		—			—			—			—			(38,260)			(38,260)
Consolidated balance at September 30, 2023		47,264,197		$	47		$	1,598,591		$	2,135		$	(1,354,055)		$	246,718